Cargando…
Role of centralized review processes for making reimbursement decisions on new health technologies in Europe
BACKGROUND: The purpose of this study was to compare centralized reimbursement/coverage decision-making processes for health technologies in 23 European countries, according to: mandate, authority, structure, and policy options; mechanisms for identifying, selecting, and evaluating technologies; cli...
Autores principales: | Stafinski, Tania, Menon, Devidas, Davis, Caroline, McCabe, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202480/ https://www.ncbi.nlm.nih.gov/pubmed/22046102 http://dx.doi.org/10.2147/CEOR.S14407 |
Ejemplares similares
-
Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework
por: Paulden, Mike, et al.
Publicado: (2014) -
HTA decision-making for drugs for rare diseases: comparison of processes across countries
por: Stafinski, Tania, et al.
Publicado: (2022) -
Decision-Making on New Non-Drug Health Technologies by Hospitals and Health Authorities in Canada
por: Stafinski, Tania, et al.
Publicado: (2019) -
A checklist for managed access programmes for reimbursement co‐designed by Canadian patients and caregivers
por: Young, Andrea, et al.
Publicado: (2018) -
Moving beyond the Court of Public Opinion: A Citizens’ Jury Exploring the Public’s Values around Funding Decisions for Ultra-Orphan Drugs
por: Stafinski, Tania, et al.
Publicado: (2022)